These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
687 related articles for article (PubMed ID: 7923207)
1. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207 [TBL] [Abstract][Full Text] [Related]
2. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines. Mellish KJ; Barnard CF; Murrer BA; Kelland LR Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420 [TBL] [Abstract][Full Text] [Related]
3. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. O'Neill CF; Hunakova L; Kelland LR Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes. Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864 [TBL] [Abstract][Full Text] [Related]
6. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318 [TBL] [Abstract][Full Text] [Related]
7. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
8. Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)]. Mellish KJ; Barnard CF; Kelland LR; Harrap KR Int J Cancer; 1994 Oct; 59(1):65-70. PubMed ID: 7927906 [TBL] [Abstract][Full Text] [Related]
9. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660 [TBL] [Abstract][Full Text] [Related]
10. Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex. O'Neill CF; Ormerod MG; Robertson D; Titley JC; Cumber-Walsweer Y; Kelland LR Br J Cancer; 1996 Oct; 74(7):1037-45. PubMed ID: 8855971 [TBL] [Abstract][Full Text] [Related]
11. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637 [TBL] [Abstract][Full Text] [Related]
12. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968 [TBL] [Abstract][Full Text] [Related]
13. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance. Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362 [TBL] [Abstract][Full Text] [Related]
14. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts. Goddard P; Valenti M; Kelland LR Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451 [TBL] [Abstract][Full Text] [Related]
15. Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Pestell KE; Hobbs SM; Titley JC; Kelland LR; Walton MI Mol Pharmacol; 2000 Mar; 57(3):503-11. PubMed ID: 10692490 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724 [TBL] [Abstract][Full Text] [Related]
17. Platinum coordination complexes which circumvent cisplatin resistance. Harrap KR; Kelland LR; Jones M; Goddard PM; Orr RM; Morgan SE; Murrer BA; Abrams MJ; Giandomenico CM; Cobbleigh T Adv Enzyme Regul; 1991; 31():31-43. PubMed ID: 1877393 [TBL] [Abstract][Full Text] [Related]
18. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Kelland LR; Murrer BA; Abel G; Giandomenico CM; Mistry P; Harrap KR Cancer Res; 1992 Feb; 52(4):822-8. PubMed ID: 1737343 [TBL] [Abstract][Full Text] [Related]
19. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Mellish KJ; Kelland LR; Harrap KR Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro. McKeage MJ; Abel G; Kelland LR; Harrap KR Br J Cancer; 1994 Jan; 69(1):1-7. PubMed ID: 8286188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]